Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St set to open higher as investors weigh earnings; PayPal jumps
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices rise as hostilities worsen in the Middle East
- ASML capacity upgrade soothes AI chip bottleneck fears
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Kosovo bans Serb minister over ethnic cleansing remarks
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
Edwards Lifesciences (EW) PT Lowered to $200 at Raymond James
April 24, 2019 8:58 AM EDTRaymond James analyst Jayson Bedford lowered the price target on Edwards Lifesciences (NYSE: EW) to $200.00 (from $210.00) while maintaining a Outperform rating.
... MoreEdwards Lifesciences (EW) PT Raised to $200 at Stifel
April 24, 2019 8:36 AM EDTStifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $200.00 (from $190.00) while maintaining a Buy rating.
Overall Solid Start to 2019 Despite Underwhelming 1Q19 TAVR Growth... MoreEdwards Lifesciences (EW) PT Raised to $186 at RBC Capital
April 24, 2019 6:39 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $186.00 (from $182.00) while maintaining a Outperform rating following results.
... MoreEdwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises Outlook
April 23, 2019 4:16 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.32, $0.10 better than the analyst estimate of $1.22. Revenue for the quarter came in at $993 million versus the consensus estimate of $989.61 million.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.10-$5.35, from $5.05 to $5.30 and versus... More
